Skip to main content
. 2020 Apr 29;25(7):1223–1232. doi: 10.1007/s10147-020-01684-z

Table 4.

Findings of disease progression involving peritoneal metastasis

Progression of peritoneal metastasis
 Aggravation of peritoneal mass, intestinal wall thickening, ascites, and intestinal stenosis
 Aggravation of intestinal obstruction or stenosis symptoms, such as decreased food intake, abdominal pain, nausea and vomiting not attributable to chemotherapy-related adverse events
 Aggravation of the feeling of abdominal fullness
 Deterioration of renal function (emergence of hydronephrosis due to aggravation of peritoneal dissemination)
 Deterioration of general condition such as a decrease in performance status determined to be caused by the original disease
 An increase in the number of times that ascites drainage is required
Disease progression difficult to determine from imaging test results
 Exacerbation of cancer pain
 Deterioration of general condition such as a decrease in performance status determined to be caused by the original disease
 The emergence and worsening of disseminated intravascular coagulation
 An increase in tumor markers